RB
Rahul Batra
About Rahul Batra
Data last updated:
Rahul Batra is a Managing Director at Beta Drugs Limited (since 2014), Whole-Time Director at Adley Formulations Private Limited (since 2018) and Director at Adley Lab Limited (since 2019), and holds 2 more current directorships. The companies operate in Pharma and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹519 Cr; the largest is Beta Drugs Limited at ₹369 Cr (FY 2025). Earlier, Rahul Batra was a Director at Kedge Pharmacia (India) Private Limited (from 2008) and Director at Adley Lifesciences Private Limited (from 2016) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Aug 2014 | 2005 | ₹369 Cr (FY 2025) | Active | |
| Whole-Time Director | 09 Oct 2018 | 2018 | ₹85.86 Cr (FY 2024) | Active | |
| Director | 28 Jun 2019 | 1992 | ₹63.38 Cr (FY 2025) | Active | |
| Director | 01 Jun 2016 | 2016 | ₹57.8 Lakh (FY 2024) | Active | |
| Director | 22 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jul 2008 | 2008 | ₹2.2 Lakh (FY 2019) | Strike Off | |
| Director | 25 May 2016 | 2016 | Strike Off | ||
| Director | 08 Dec 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahul Batra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Batra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Batra
Rahul Batra currently holds 5 directorships: Beta Drugs Limited (Managing Director, since 01 Aug 2014, revenue ₹369 Cr (FY 2025)); Adley Formulations Private Limited (Whole-Time Director, since 09 Oct 2018, revenue ₹85.86 Cr (FY 2024)); Adley Lab Limited (Director, since 28 Jun 2019, revenue ₹63.38 Cr (FY 2025)); Bt Associates Private Limited (Director, since 01 Jun 2016, revenue ₹57.8 Lakh (FY 2024)); Beta Research Private Limited (Director, since 22 Jun 2022).
Rahul Batra was first appointed on 24 Jul 2008 as Director at Kedge Pharmacia (India) Private Limited. The most recent appointment on record is 22 Jun 2022 at Beta Research Private Limited.
The 4 current companies of Rahul Batra that report revenue have a combined latest revenue of ₹519 Cr: Beta Drugs Limited ₹369 Cr (FY 2025); Adley Formulations Private Limited ₹85.86 Cr (FY 2024); Adley Lab Limited ₹63.38 Cr (FY 2025); Bt Associates Private Limited ₹57.8 Lakh (FY 2024).
Rahul Batra held 3 earlier board appointments: Kedge Pharmacia (India) Private Limited (Director, from 24 Jul 2008); Adley Lifesciences Private Limited (Director, from 25 May 2016); Adley Resorts Private Limited (Director, from 08 Dec 2009).
The current boards of Rahul Batra's companies include Ajay Mahipal (Beta Drugs Limited), Ashutosh Shukla (Beta Drugs Limited), Balwant Singh (Beta Drugs Limited), Lalit Kumar Watts (Beta Drugs Limited), Manmohan Khanna (Beta Drugs Limited), Monica Jain (Beta Drugs Limited), among others.